| 000 | 01211 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250511165022.0 | ||
| 264 | 0 | _c19750905 | |
| 008 | 197509s 0 0 eng d | ||
| 022 | _a0045-5083 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFalk, R E | |
| 245 | 0 | 0 |
_aUse of oral and intraperitoneal BCG in the treatment of malignant melanoma and adenocarcinoma. _h[electronic resource] |
| 260 |
_bCanadian journal of otolaryngology _c1975 |
||
| 300 |
_a39-45 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xtherapy |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBCG Vaccine _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGastrointestinal Neoplasms _xtherapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 | _aInjections, Intraperitoneal |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _xtherapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMycobacterium bovis |
| 650 | 0 | 4 | _aSkin Tests |
| 700 | 1 | _aLandi, S | |
| 700 | 1 | _aCohen, Z | |
| 700 | 1 | _aFalk, J A | |
| 700 | 1 | _aAmbus, U A | |
| 700 | 1 | _aLanger, B | |
| 773 | 0 |
_tCanadian journal of otolaryngology _gvol. 4 _gno. 1 _gp. 39-45 |
|
| 999 |
_c1100868 _d1100868 |
||